What is the appropriate evaluation and management for a 24-year-old woman presenting with dyspareunia (vaginal pain) that occurs only during intercourse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation and Management of Dyspareunia in a 24-Year-Old Woman

A 24-year-old woman with pain only during intercourse requires a systematic evaluation beginning with detailed history to distinguish superficial from deep pain, followed by targeted physical examination to identify specific anatomical triggers, with treatment directed at the underlying cause—most commonly vulvodynia, pelvic floor dysfunction, or dermatologic conditions in this age group.

Initial Assessment Approach

The evaluation must first establish the pain location and characteristics 1, 2:

  • Superficial (entry) pain: Suggests vulvodynia (including vestibulitis), inadequate lubrication, dermatologic conditions (lichen sclerosus), or pelvic floor muscle dysfunction
  • Deep pain: Points toward endometriosis, pelvic adhesions, bladder pain syndrome, or adnexal pathology

Critical History Elements

Document the following specific details 3, 2:

  • Pain timing: With initial penetration versus deep thrusting
  • Pain quality: Sharp, burning, aching, or pressure-like
  • Trigger factors: Specific positions, stress, certain foods/beverages
  • Associated symptoms:
    • Urinary symptoms (frequency, urgency, pain with bladder filling) suggesting bladder pain syndrome
    • Constipation or painful defecation
    • Cyclic pelvic pain suggesting endometriosis
  • History of trauma: Physical or sexual abuse (use preformed questionnaires for this sensitive topic) 3
  • Contraceptive use: Oral contraceptives are associated with vestibulodynia 3
  • Previous infections: UTIs, sexually transmitted infections

Physical Examination Strategy

The examination should systematically reproduce and localize the pain 3, 2:

External Genital Examination

  • Inspect for porcelain-white plaques or ecchymosis (lichen sclerosus) 4
  • Look for dermatologic changes, atrophy, or fissures
  • Cotton swab test: Touch the vestibule at 2,4,6,8, and 10 o'clock positions—localized sharp pain indicates vestibulodynia 2

Vaginal and Pelvic Examination

  • Assess for involuntary pelvic floor muscle spasm during speculum or finger insertion (vaginismus) 2
  • Palpate lateral vaginal walls for pelvic floor muscle tenderness 3
  • Evaluate urethral and bladder base tenderness
  • Bimanual exam to assess uterine, adnexal, and cervical motion tenderness

Common pitfall: Rushing the examination in a patient with pain—proceed slowly, explain each step, and allow the patient to guide the pace.

Baseline Investigations

Based on examination findings 3:

  • Urine dipstick and culture: Rule out UTI (prerequisite for other diagnoses)
  • STI testing: Chlamydia and ureaplasma if indicated
  • 3-day bladder diary: If urinary symptoms present (small frequent voids suggest bladder pain syndrome)
  • Food diary: If symptoms flare with specific foods/beverages

Treatment Algorithm by Diagnosis

For Vestibulodynia (Most Common in Young Women)

This presents as superficial, provoked pain localized to the vestibule 5, 6:

  • First-line: Pelvic floor physical therapy for associated muscle dysfunction 7, 8
  • Topical treatments: Lidocaine ointment before intercourse
  • Neuromodulating medications: Gabapentin or tricyclic antidepressants for neuroproliferative pain 5
  • Avoid irritants: Soaps, douches, tight clothing

For Pelvic Floor Muscle Dysfunction

Presents with pain on penetration and palpable muscle tenderness 7, 8:

  • Pelvic floor physical therapy is the primary treatment 8
  • Consider botulinum toxin A for refractory cases 9
  • Vaginal dilators with progressive desensitization

For Dermatologic Conditions (Lichen Sclerosus)

If porcelain-white lesions or ecchymosis present 4:

  • Ultrapotent topical corticosteroids (clobetasol propionate 0.05%)
  • Can be safely used long-term with monitoring
  • Note: 65.5% of dermatologic causes respond satisfactorily to appropriate treatment 6

For Deep Dyspareunia

Requires broader pelvic evaluation 8:

  • Consider imaging (ultrasound or MRI) for endometriosis, adhesions, or masses
  • Refer to gynecology if adnexal pathology suspected
  • Evaluate for bladder pain syndrome if urinary symptoms present 3

Key Clinical Pearls

The majority of chronic vulval pain has either a dermatological cause (61.3%) or neuromuscular dysfunction (38.7%), and both are potentially treatable 6. In this retrospective study of 525 patients, 52.7% had satisfactory treatment responses when appropriately diagnosed.

Important caveat: Many women are reluctant to report sexual pain—providers must proactively ask about dyspareunia in a safe, nonjudgmental manner 1. The condition significantly impacts quality of life, relationships, and self-esteem.

Multimodal approach is often necessary: Even when a primary cause is identified, addressing concurrent pelvic floor dysfunction, psychological factors, and partner communication improves outcomes 7, 9. The neurophysiologic mechanisms involve both peripheral and central sensitization, explaining why isolated treatments may be insufficient.

At 24 years old, genitourinary syndrome of menopause is not relevant—focus on vestibulodynia, pelvic floor dysfunction, dermatologic conditions, and deep causes like endometriosis 8.

References

Research

Dyspareunia: Etiology, presentation, and management.

The Nurse practitioner, 2023

Research

Evaluation and differential diagnosis of dyspareunia.

American family physician, 2001

Guideline

management of bladder pain syndrome: green-top guideline no. 70.

BJOG : an international journal of obstetrics and gynaecology, 2017

Research

Evaluation and Treatment of Sexual Pain Disorders.

Clinical obstetrics and gynecology, 2025

Research

The aetiology of chronic vulval pain and entry dyspareunia: a retrospective review of 525 cases.

The Australian & New Zealand journal of obstetrics & gynaecology, 2017

Research

Managing Female Sexual Pain.

The Urologic clinics of North America, 2021

Research

Assessment and management of dyspareunia in peri- and postmenopausal women: A phenotype-based gynecologic approach.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.